Status: Recruiting
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
Primary Objective: This is a study to investigate the feasibility of harvesting, expanding, and selecting T lymphocytes from cancer patients and healthy volunteers. The preliminary objective of this study is aimed at selecting PD-1+ and CTLA4+ T cells and other cellular fractions from peripheral blood of cancer patients and healthy volunteers by using specific conjugated antibodies, evaluating their functional ex vivo anti-tumor cytotoxicity against targeted autologous tumor cells.
Participants needed: 1,500
Trial details
Age: 5+Biological sex: AllType: ObservationalSponsor: BioCytics, Inc.Updated: Mar 18, 2026Locations: 1
Eligibility criteria
Male or Female Adult ≥ 18 years of age. [+28]
Subjects with active infection requiring therapy (fever, localizing source) will... [+2]